Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-23-033896
Filing Date
2023-04-28
Accepted
2023-04-28 16:15:45
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2022a1_aditxt.htm   iXBRL 10-K/A 321923
2 CERTIFICATION f10k2022a1ex31-1_aditxt.htm EX-31.1 10861
3 CERTIFICATION f10k2022a1ex31-2_aditxt.htm EX-31.2 10960
4 CERTIFICATION f10k2022a1ex32-1_aditxt.htm EX-32.1 5284
  Complete submission text file 0001213900-23-033896.txt   613862

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adtx-20221231.xsd EX-101.SCH 3202
6 XBRL DEFINITION FILE adtx-20221231_def.xml EX-101.DEF 16881
7 XBRL LABEL FILE adtx-20221231_lab.xml EX-101.LAB 34736
8 XBRL PRESENTATION FILE adtx-20221231_pre.xml EX-101.PRE 17940
10 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022a1_aditxt_htm.xml XML 6045
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39336 | Film No.: 23866418
SIC: 2834 Pharmaceutical Preparations